Skip to content

News & updates

Press Releases

A*STAR, TTSH and MiRXES launch multiplex COVID-19 kit that tests for SARS-CoV-2 and Influenza A and B

18 January, 2021

MiRXES and NUHS launch GASTROClear blood test for early detection of gastric cancer

23 October, 2020

Data from pulmonary hypertension collaboration with Janssen-J&J presented at ERS Congress 2020

8 September, 2020

Webinar: Launch of SS 656 Design, Development and Validation of miRNA-based Diagnostics (Video)

4 September, 2020

MiRXES launches Japan subsidiary

1 June, 2020

MiRXES partners Esco Aster for mobile COVID-19 diagnostic labs

18 May, 2020

MiRXES to mass produce and distribute A*STAR Singapore’s tested and proven SARS-CoV-2 RT-PCR test

23 April, 2020

MiRXES collaborates with NUS and DxD Hub to move Singapore to the forefront of global microRNA research and application

29 January, 2020

MiRXES to collaborate with Beth Israel Deaconess Medical Centre

26 June, 2018
« Prev12Next »

Media Coverage

MiRXES test kit that can detect COVID-19 and seasonal flu gets HSA’s approval
18 January, 2021 /
COVID-19 and the coming of age of Singapore science
14 December, 2020 /
MiRXES Chief Scientific Advisor in SWITCH 2020 Video: 25 People, One Story (Video)
10 December, 2020 /
MiRXES CEO on SWITCH 2020 panel: Internationalisation of deep tech (Video)
9 December, 2020 /
MiRXES sets out to sell gastric cancer test across Asia
4 November, 2020 / ,
Channel News Asia report on GASTROClear (Video)
23 October, 2020 /
GASTROClear being evaluated for use in primary healthcare
23 October, 2020 /
IPOS Innovation for Humanity Award for MiRXES (Video)
25 August, 2020 /
Singapore ramps up test kit production to meet local and global demand
19 August, 2020 /
MiRXES and other homegrown firms in virus fight
11 August, 2020 /
MiRXES leading the way in microRNA technology
21 May, 2020 /
Home-grown firms linked to pandemic work will continue to attract demand, investments
10 May, 2020 /
MiRXES is 102nd on Financial Times ranking of Asia-Pacific High Growth Companies
21 April, 2020 /
COVID-19 putting MiRXES and Singapore on global deeptech radar
14 April, 2020 /
MiRXES heeding the call for COVID-19 testing
30 March, 2020 /
MiRXES — A game changer in microRNA applications
3 March, 2020 /
Singapore clears Fortitude Kit SARS-CoV-2 test for clinical use
3 March, 2020 /
MiRXES to mass-produce Singapore-developed Fortitude Kit SARS-CoV-2 test kits
18 February, 2020 / ,
MiRXES named Singapore’s fastest growing company in the health sector from 2015-2018
15 January, 2020 /
Timely guidance for MiRXES from Pro-Enterprise Panel
7 November, 2019 /
GASTROClear blood test for stomach cancer first step to ending all cancer deaths
18 September, 2019 /
MiRXES has a real shot at stamping out cancer deaths
8 July, 2019 /
Seniors tested for stomach cancer with GASTROClear at free screening in Teck Ghee
18 May, 2019 /
MiRXES co-founder Zhou Lihan’s entrepreneurial journey
14 May, 2018 /
MiRXES collaborates with Johnson & Johnson to develop miRNA test for lung cancer
16 January, 2018 /
MiRXES aims to make cancer tests more accessible
21 November, 2016 /
Venturecraft invests in MiRXES
6 September, 2016 /
MiRXES creates alternative test for cancer
23 August, 2016 /
Screening for early stage stomach cancer with a blood test
21 March, 2016 /
« Prev12Next »